Epigenetic Mechanisms Involved in Huntington's Disease Pathogenesis

被引:0
|
作者
Glajch, Kelly E. [1 ]
Sadri-Vakili, Ghazaleh [1 ]
机构
[1] Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis, Boston, MA 02114 USA
关键词
Epigenetics; Huntington's disease; DNA methylation; histone modifications; huntingtin; transcription;
D O I
10.3233/JHD-140134
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Transcriptional dysregulation is an early event and may be an important pathological mechanism in Huntington's disease (HD). However, the exact process that leads to alterations in gene expression in HD is not clear. One potential mechanism underlying transcriptional abnormalities in HD may be epigenetic alterations which regulate gene expression without changing the DNA sequence. Previous work has demonstrated that epigenetic marks, such as DNA methylation and post-translational modifications of histone proteins, are significantly altered in HD cellular and animal models as well as HD patients. Furthermore, studies have shown a therapeutic role for histone deacetylase (HDAC) inhibitors in numerous HD models. Here, we review a range of studies describing epigenetic changes in HD as well as several potential therapeutics that target aberrant epigenetic alterations in HD.
引用
收藏
页码:1 / 15
页数:15
相关论文
共 50 条
  • [21] Recent advances on the pathogenesis of Huntington's disease
    Petersén, Å
    Mani, K
    Brundin, P
    [J]. EXPERIMENTAL NEUROLOGY, 1999, 157 (01) : 1 - 18
  • [22] Are there multiple pathways in the pathogenesis of Huntington's disease?
    Aronin, N
    Kim, M
    Laforet, G
    DiFiglia, M
    [J]. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES, 1999, 354 (1386) : 995 - 1003
  • [23] Oxidative damage in Huntington's disease pathogenesis
    Browne, Susan E.
    Beal, M. Flint
    [J]. ANTIOXIDANTS & REDOX SIGNALING, 2006, 8 (11-12) : 2061 - 2073
  • [24] Huntington's disease: Pathogenesis to animal models
    Kumar P.
    Kalonia H.
    Kumar A.
    [J]. Pharmacological Reports, 2010, 62 (1) : 1 - 14
  • [25] Insights into the molecular pathogenesis of Huntington's disease
    Bates, G
    [J]. JOURNAL OF MEDICAL GENETICS, 2001, 38 : S30 - S30
  • [26] Mechanisms of neurodegeneration in Huntington's disease
    Gil, Joana M.
    Rego, Ana Cristina
    [J]. EUROPEAN JOURNAL OF NEUROSCIENCE, 2008, 27 (11) : 2803 - 2820
  • [27] Mechanisms of neurodegeneration in Huntington's disease
    Gil, Joana M.
    Rego, Ana Cristina
    [J]. EUROPEAN JOURNAL OF NEUROSCIENCE, 2008, 28 (10) : 2156 - 2156
  • [28] PATHOGENIC MECHANISMS IN HUNTINGTON'S DISEASE
    Jones, Lesley
    Hughes, Alis
    [J]. PATHOPHYSIOLOGY, PHARMACOLOGY, AND BIOCHEMISTRY OF DYSKINESIA, 2011, 98 : 373 - 418
  • [29] Environmental Impact on the Epigenetic Mechanisms Underlying Parkinson's Disease Pathogenesis: A Narrative Review
    Angelopoulou, Efthalia
    Paudel, Yam Nath
    Papageorgiou, Sokratis G.
    Piperi, Christina
    [J]. BRAIN SCIENCES, 2022, 12 (02)
  • [30] Cellular and molecular mechanisms involved in the selective vulnerability of striatal projection neurons in Huntington's disease
    Perez-Navarro, E.
    Canals, J. M.
    Gines, S.
    Alberch, J.
    [J]. HISTOLOGY AND HISTOPATHOLOGY, 2006, 21 (11) : 1217 - 1232